Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Nanotechnology Startup Challenge in Cancer Announces 10 Winning Teams to Launch Startups around Promising Inventions
  • USA - English
  • USA - English


News provided by

The Center for Advancing Innovation

Jul 26, 2016, 06:30 ET

Share this article

Share toX

Share this article

Share toX

Nanotechnology  Startup Challenge in Cancer (NSCSquared)
Nanotechnology Startup Challenge in Cancer (NSCSquared)

The winners will now have a unique opportunity to get expert assistance in creating their startups and bringing to market new therapies for some of the most difficult to treat cancers.

Post this

Bethesda, Maryland (PRWEB) July 26, 2016 -- Ten winners of the Nanotechnology Startup Challenge in Cancer (NSC2) were announced today by the Center for Advancing Innovation (CAI). The challenge featured eight inventions, conceived and developed by scientists from three participating institutes of the National Institutes of Health (NIH) -- the National Cancer Institute (NCI), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Heart, Lung, and Blood Institute (NHLBI) -- as well as extramural, “third-party” inventions, which were discovered and advanced outside of the NIH. The winning entrepreneurs were selected based on 10-page business plans, financial models, and 20-minute “live pitches” to a panel of expert judges.

Winning teams will move forward to the third and final phase of the challenge - the Startup Phase. In this phase, the winning teams will form their startups to advance cancer nanotechnology inventions. Teams that received the Innovation Excellence Award will receive a $2000 cash award. All teams that were accepted into the challenge were placed in an accelerator program with a rigorous advancement process, which was independent from the inventions they chose, and only those teams who met the criteria advanced to Phase 2.

The Nanotechnology Startup Challenge is supported by regional partners such as MedImmune, the global biologics research and development arm of AstraZeneca, which shares a vision of strengthening the Virginia, Maryland, and Washington, D.C. regional biomedical ecosystem and spurring economic growth. Two winners are located in the BioHealth Capital Region.

The winning teams, their chosen nanotechnology inventions, and their target indications are:

Illinois Institute of Technology - RA
Latona Therapeutics
NIH Invention #1
Triple-Negative Breast Cancer (TNBC)
Winner - Innovation Spotlight Award

Medical College of Wisconsin - GX
NanoRed Therapeutics
NIH Invention #1
Childhood RMS; Sarcoma + Breast Cancer
Winner - Innovation Excellence Award

Thomas Jefferson University - MW
Precision Nanotech
NIH Invention #1
Solid Tumors - Licensing Platform
Winner - Innovation Spotlight Award

University of Cambridge - ZB
RNAissance
NIH Invention #2
Glioblastoma Multiforme (GBM)
Winner - Innovation Excellence Award

University of Cambridge - JC
OneTest Diagnostics
NIH Invention #4
Colorectal Cancer
Winner - Innovation Spotlight Award

Wake Forest University - DAP
Advanced NanoTech
NIH Invention #4
Non-Small Cell Lung Cancer
Winner - Innovation Spotlight Award

University of Maryland School of Medicine - CV
NANOBERNETICS
NIH Invention #4
Chronic Myeloid Leukemia CML Detection
Winner - Innovation Spotlight Award

Medical University of South Carolina - EDH
NIH Invention #4
HPV+ Cancer Diagnostic Screening
Winner - Innovation Excellence Award

Wake Forest School of Medicine - ET
AuTACA
NIH Invention #5
Colon Cancer
Winner - Innovation Excellence Award

ECF Biosolutions - ECF
Carillon BioPharma
Third Party Invention
Metastatic Melanomas and Triple Negative Breast Cancers (TNBCs)
Winner - Innovation Excellence Award

“The challenge has provided a new channel to advance practical applications of nanotechnology to cancer and further galvanized the community as a whole,” said Piotr Grodzinski, Ph.D., director of the NCI Alliance for Nanotechnology in Cancer program. “Importantly, the entrepreneurial training and engagement of industry mentors in the challenge facilitates a new bond connecting industry and the research community enabling more effective technology transfer.”

NSC2 opened for entry in October 2015 and enrolled over 250 aspiring entrepreneurs and 28 teams. Throughout the challenge, these teams participated in CAI’s required accelerator training and were educated by leading experts from the biotechnology industry, venture capital, universities, foundations, and government. This virtual training was offered free of charge to NSC2 participants and included over 30 webinars on commercialization planning, research and development planning, intellectual property, regulatory strategy, financial modeling, and more. In the final phase of NSC2, each winning team will be mentored on launching their startup, incorporating a business, licensing, forming a management team, and raising seed money from investors.

"When this challenge was announced, I was hopeful that it would inspire innovators from across the country to help NIH bring promising inventions to patients. In fact, the challenge attracted worldwide interest, with participants representing 28 cities across 13 countries," said Lloyd Whitman, Assistant Director for Nanotechnology and Advanced Materials at the White House Office of Science and Technology Policy. "The winners will now have a unique opportunity to get expert assistance in creating their startups and bringing to market new therapies for some of the most difficult to treat cancers."

“The promise of the startups being launched from the challenge is evidence of the innovation that runs strong throughout the BioHealth Capital Region,” said Reg Seeto, Vice President, Head of Partnering and Strategy at MedImmune. “Partnered with CAI, we will continue to accelerate the development of such new initiatives, putting in place high-impact startups within the biotech ecosystem.”

Rosemarie Truman, founder and CEO of the CAI added, “Now in our fourth challenge, the Nanotechnology Startup Challenge in Cancer creates another platform to further amplify entrepreneurial platforms around the world given the rigorous accelerator education offered. We continue to raise the bar in the challenge framework to boost and accelerate the advancement of life-saving biomedical inventions.”

For more information on the challenge, please visit http://www.nscsquared.org.

ABOUT CAI:
The Center for Advancing Innovation (CAI) is a global public-private partnership non-profit focused on creating a virtuous circle of innovation and driving growth breakthroughs through novel, creative paradigms and models. CAI's mission is to accelerate and increase the volume of technology transfer, translational research, commercialization, and entrepreneurship in various fields of research, including biomedical research, to make more research available to the world for educational and innovation purposes, improve the economy, and positively impact world health. Through its NIH-sponsored Breast Cancer Startup Challenge and Neuro Startup Challenge, CAI has launched 33 startups and trained over 1000 entrepreneurs. For additional information about CAI, please visit http://www.thecenterforadvancinginnovation.org

Rosemarie Truman, The Center for Advancing Innovation, http://www.thecenterforadvancinginnovation.org/, +1 (202) 438-2208, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.